Practice of Exclusive Breastfeeding: A Narrative Review of Its Relevance and Added Value as a Public Health Strategy to Reduce the Double Burden of Malnutrition

Abstract

Among public health guidelines and strategies for optimal children’s growth, exclusive breastfeeding in the first six months occupies a pivotal place. The present review provides an overview of the composition of human breast milk and the relevance of exclusive breastfeeding as a public health tool that can improve children’s health as well as mother’s wellbeing. Analyses encompass nutrients supply to children, children’s immune system setting and maturation, cognitive and psychomotor development, epigenetic regulation, and microbiome establishment. The relevance of exclusive breastfeeding as a public health strategy is discussed before reviewing the level of application of this strategy worldwide. Furthermore, breastfeeding evaluation methods are presented alongside factors associated with exclusive breastfeeding practice.

Share and Cite:

Kabassina, M.E., Souho, T., Bomboma, D., Aglago, E.K., Compaoré, E., Abli, A.E. and Amouzou, S.K. (2026) Practice of Exclusive Breastfeeding: A Narrative Review of Its Relevance and Added Value as a Public Health Strategy to Reduce the Double Burden of Malnutrition. Food and Nutrition Sciences, 17, 375-399. doi: 10.4236/fns.2026.174027.

1. Introduction

One of the most challenging targets to be attained by public health interventions for social development, especially in low- and middle-income countries, is to assure wellbeing to all children and reduce the mortality under five years old [1]. This objective is considered a priority globally as the development and evolution of any society is contingent on the presence of a healthy human capital. It is now well established that optimal nutrition in the first thousand days is a critical determinant of the health status of children, adolescents, and adults [2] [3]. Regarding specially the first 6 months of life, existing evidence substantially shows that exclusive breastfeeding confers significant benefits [4]. Exclusive breastfeeding protects the newborn against several communicable and noncommunicable pathologies and promotes optimal development of organs, growth, cognitive and psychomotor development [5] [6].

The World Health Organization (WHO) recommends exclusive breastfeeding for the first six months, followed by continued breastfeeding up to the age of two years old [7]. Breastfeeding, especially exclusive breastfeeding for six months, has a significant impact on reducing mortality from the two leading causes of infant death: diarrhea and pneumonia, as well as all-cause mortality [8]. Despite the efforts of this organization, general observations showed that exclusive breastfeeding for newborns is not followed in the same fashion in all regions as its initiation and duration is multifactorial and associated with factors such as living standards, social and religious considerations. Since the first publication of these recommendations a couple of decades ago, several studies have been carried out on breastfeeding and its effects on the mother and newborn dyads, as well as on approaches to implement and promote its practice. To encourage the practice of exclusive breastfeeding, the WHO, the United Nations Children’s Fund (UNICEF) and ministries of health in several countries have initiated and supported the world breastfeeding week every year since 1992, during the first week of August.

As key tools in exclusive breastfeeding promotion programs, exclusive breastfeeding evaluation methods underwent several evolutions towards more precise, less invasive and reduced time. In this review, we analyze the relevance and epidemiology of exclusive breastfeeding before critically discussing factors limiting its practice as well as methods to evaluate the practice of exclusive breastfeeding and approached to implement it.

2. Methods

A literature search was performed using Pubmed and Scopus databases without any specific limitation regarding publication period. Several search syntaxes were used in order to cover the initial purpose of covering the main aspects that are relevant as key factors that can modulate the practice and the outcome of breastfeeding. The following search terms were used independently: “breast milk composition”; “breast milk” AND “nutrient” OR “micronutrient” OR “microRNA” OR “microbiome” OR “hormone”; “breastfeeding” AND “practice” OR “health outcome” OR “evaluation method”.

No strict restriction regarding study design or population was applied in order to capture a broad range of scientific evidence related to breastfeeding practices and outcomes. Articles were considered eligible if they addressed aspects related to breast milk composition, breastfeeding practices, health outcomes, or methods used to evaluate breastfeeding. Studies published in English or French were considered.

Articles were included when they provided relevant information, while studies that were clearly unrelated to the topic were excluded after title, abstract, or full-text screening. References in the retained articles were also browsed, allowing additional documents, including reports and working documents from international institutions. The screening and selection process was conducted by at least two team members, and any disagreement regarding the inclusion of a study was resolved through discussion until consensus was reached.

Collected data were organized and analyzed in order to generate a narrative review. The evidence from the selected publications was synthesized narratively by identifying recurring themes and key findings across studies, which were then integrated to support the interpretation and conclusions of this review. The study was meant to provide a large view and elements to answer the following questions: i) Should breastfeeding-promoting programs be pursued? ii) What is the advantages of breastfeeding? iii) Which method should be used to evaluate the practice of breastfeeding?

3. Results and Discussions

3.1. Content of Human Breast Milk

Human breast milk (HBM) is a stable emulsion composed of a mixture of water and fat matters. It contains water (87.5%) and several macronutrients, micronutrients and certain bioactive factors [9]. It is a dynamic food with a composition related to the mother’s nutrition and the time laps from the baby birth. During the breastfeeding period, the milk’s composition varies to adapt to the child’s changing nutritional needs [10]. It is an important source of energy (670 kcal/l). It contains nutrients and a variety of bioactive factors such as hormones, cytokines, leukocytes, immunoglobulins, lactoferrin, lysozyme, stem cells, human milk oligosaccharides, microbiota, and microRNAs [11]. Because of its ability to provide optimal nutrient intakes and numerous bioactive factors, breast milk is considered the optimal food for newborns.

3.1.1. Proteins

HBM contains 8 to 12 g/L proteins with caseins being the most abundant representing around 40% of all proteins in the milk. This protein content is below the average in other mammals; however, it is perfectly adapted to meet the enzymatic immaturity and specific protein needs of infants [12] [13]. Other proteins in HBM encompass various proteins with physiological functions, such as nutrition, antibacterial properties, immune system regulation, and promotion of digestion and nutrients absorption [14] [15]. Additionally, it contains specific proteins, including lactoferrin (which facilitates iron absorption and immune system function) and lysozymes. Furthermore, HBM contains vitamin and hormone transporters, enzymes, immunoglobulins (especially IgA) and other proteins that provide immune protection or stimulate the child’s immune system [16].

The bioactive proteins in breast milk play a role in digestion and nutrient absorption, but they also have enzymatic activities, facilitate the growth of many tissues and help infants reaction against pathogens [17]. Immunological factors include antibodies such as IgA, cytokines and immune cells (lymphocytes, leukocytes, neutrophils, etc) as well as antimicrobial proteins and peptides like lactoferrin and lysozymes [18].

3.1.2. Carbohydrates

Principal carbohydrates recorded in HBM are oligosaccharides and monosaccharides. The most abundant carbohydrate is lactose which is present at concentrations around 63 g/L whereas the whole carbohydrates content is around 75 g/L. Apart from lactose, the other carbohydrates are D-glucose, D-galactose, N-acetylglucosamine, L-fucose, and sialic acid [19]. Other oligosaccharides observed in the milk presents the particularity of having a lactose motif at their reducing end [20].

Human milk carbohydrates are well known for their role of energetic nutrients however, several functional activities of milk have been reported to be attributable to milk oligosaccharides. These oligosaccharides are likely prebiotic factors that promotes the proliferation of probiotic bacteria such as Bifidobacterium in the gastrointestinal tract of breastfed infants [20] [21]. In addition, they might confer to breastfed infants a passive protection regarding some pathogens. Indeed, by interfering in the process of pathogenic bacteria adherence with intestinal mucosa, they provide a nonspecific protection given that bacterial adherence is a necessary step in gastrointestinal infections with bacteria such as Escherichia coli, Helicobacter jejuni, Shigella strains, Salmonella species, Vibrio cholerae [22] [23]. Moreover, the HBM’s oligosaccharides might have a systemic effect in addition to their local activity in the gut. This implies that these oligosaccharides are assimilated. In effect, several evidence show that these oligosaccharides play an important role in the postnatal brain development [24].

3.1.3. Lipids

Lipids in the milk constitute the highest source of energy in the milk contributing to ranges from 40 to 55 % of the milk’s total energy [25]. Structurally, triglycerides are the most abundant lipids in the milk where free fatty acids, monoglycerides, diglycerides, phospholipids and cholesterol are also observed. These fat matters are grouped in lipidic globules with glycerides in the center and phospholipids at the surface stabilizing interactions with the aqueous phase of the milk [26] [27].

The fat composition of HBM is diverse. Breast milk contains polyunsaturated fatty acids (PUFAs), essential fatty acids (EFAs), particularly linoleic acid and alpha-linolenic acid of the Omega 6 and Omega 3 families, respectively [28]. It also contains longer-chain polyunsaturated fatty acids , including arachidonic acid and docosahexaenoic acid [29]. Short chain fatty acids also are present in the milk and present the advantage of providing energy to breastfed infants and help in maturating gastrointestinal tract. Additionally, although in small amounts, sphingomyelins are present in breast milk and seem to play a crucial role in the development of infants nervus system [30]. The average quantity of lipids in a liter of breast milk is estimated to be 35 grams. Additionally, HBM also contains a considerable amount of cholesterol, with levels ranging from 150 to 200 mg/L [31] [32].

3.1.4. Micronutrients

A significant proportion of HBM is composed of micronutrients essential for normal infant growth. Minerals in breast milk include sodium, calcium, magnesium, chloride, potassium, iron, zinc, chromium, manganese, copper, phosphorus, selenium, and iodine [33]. The most abundant mineral in both colostrum and mature milk is chloride (600 to 800 mg/Lin colostrum and 400 to 450 mg/L in mature milk) followed by potassium (600 to 800 mg/L in colostrum and 400 to 550 mg/L in mature milk) and sodium (300 to 400 mg/L in colostrum and 150 to 250 mg/L in mature milk). Calcium and phosphorus, key elements necessary for bones formation, are important minerals in both colostrum and mature HBM [34] [35].

Minerals are required for many vital metabolic pathways including the building and maintenance of strong bones and teeth, the production of hematopoietic cells, the regulation of immune and nervous systems, muscles contraction, and the protection of cells from oxidative damages [36]. More information on milk’s mineral composition including microelements such as manganese, iodine, selenium, copper and zinc is presented in the literature [34] [35].

HBM can adequately provide all vitamins requirements, provided that the mother’s diet is balanced [29] [37] [38]. However, the most commonly abundant vitamins as presented in several studies include vitamins A, B1, B2, B6, B12, C, D, E, and K (Table 1).

Table 1. Human breast milk’s content in vitamins (per 100 mL).

Vitamin

Concentration

Vitamin A

40 - 65 µg

Vitamin D

0.2 - 0.6 µg (8 - 24 IU)

Vitamin E

0.2 - 0.4 mg

Vitamin K

1.5 µg

Vitamin C

3 - 10 mg

Vitamin B1 (Thiamine)

14 µg

Vitamin B2 (Riboflavin)

40 µg

Vitamin B3 (Niacin)

160 µg

Vitamin B5 (Pantothenic Acid)

220 µg

Vitamin B6 (Pyridoxine)

12 µg

Vitamin B7 (Biotin)

8 - 10 µg

Vitamin B9 (Folate)

38 - 54 ng

Vitamin B12 (Cobalamin)

0.1 - 0.5 µg

3.1.5. Hormones and Growth Factors

Among the most extensively studied bioactive components, milk hormones occupy a central position. Several studies have detected the presence of various hormones in HBM, including leptin, adiponectin, gonadotropin-releasing hormone (GnRH), insulin, estrogen, androgens, gastrin, progesterone, resistin, ghrelin and Insulin-like Growth Factor 1 [39] [40]. The precise functions of these hormones remain to be fully elucidated; however, it is postulated that they play a role in various developmental and growth processes, offering protection to infants against certain diseases including obesity [40]-[43].

Leptin, a hormone secreted by adipocytes, was detected in human milk and proven to play several roles in infants’ metabolic regulations. It is involved in the regulation of infant’s food intake, energetic metabolism, fat accumulation and body composition from the earliest stages of development [43]-[45]. Recent studies have indicated that leptin, in interaction with other adipokines such as adiponectin, may play a role in the long-term metabolic programming and reprogramming of the newborn [42] [46]. Adiponectin is the most abundant adipose-specific protein, discovered in breast milk, and its multiple functions have only recently begun to emerge [47]. Ghrelin, another orexigenic hormone observed in breast milk has been shown to stimulate the secretion of growth hormone, increase appetite, and play a role in the regulation of body weight in newborns. it also plays a role in decreasing fat utilization and increasing adipose reserves, thus promoting normal infant growth [48] [49].

The insulin resistance associated hormone, resistin was found in human milk but its role in infants’ metabolism is not well understood [50]. However, the umbilical serum resistin levels correlate positively with maternal serum resistin levels and negatively with neonatal birth weight [51]. This suggests that resistin may have a role in the control of fetal growth and may be involved in the regulation of appetite and the metabolic development of infants [41]. Insulin-like Growth Factor I (IGF-I), a polypeptide primarily produced by the liver, acts as the main mediator of growth hormone activity. Studies have identified growth factors in human milk, suggesting a potential role in promoting cell proliferation [52]. Additionally, IGF-binding proteins (IGFBPs) have been detected in the breast milk of both term and preterm infants [53]. The origin and function of obestatin, a peptide found in breast milk, are unclear, although it may influence appetite, gastrointestinal motility and neurobehavioral processes such as memory, sleep and anxiety [41]. Growth factors present in human milk play a critical role in facilitating the maturation of the intestinal mucosal barrier, providing both growth-promoting and protective effects to the immature neonatal gastrointestinal tract. In particular, vascular endothelial growth factor (VEGF), hepatic growth factor (HGF), and epidermal growth factor (EGF) are important contributors [29] [54].

In summary, hormones, growth factors, and metabolites present in breast milk interact to form a complex functional network, impacting the infant’s overall development beyond the nutritional aspects alone. Nevertheless, despite substantial progress in the characterization of these compounds, their precise mechanisms of action and long-term effects remain largely unresolved.

3.1.6. Microbes in Human Breast Milk

HBM has long been considered sterile, but recent studies have shown that it is a rich source of microbes that can have an impact on infants’ health [55]. Microbes observed in the milk are mostly composed of mother’s skin commensal flora elements, mother’s digestive tract’s bacteria and microbes of the child’s mouth. They may also derive from the maternal mucosa-associated lymphoid tissue through a specialized homing mechanism. In this process, dendritic cells and macrophages are thought to transport microbes from the mother’s mucosal surfaces to the lactating mammary gland. This microbiome is dynamic and factors implied in its composition are still not well understood. Some evidence suggests that lactation stage, mother’s body mass index, mother’s diet, and mother’s antibiotic use play an important role in the modulation of milk microbiome [56]. Microbes in human milk play an important role in regulating cytokine production in the enteric nervous system and maintaining mucosal immune function in the infant [55] [57].

Given the major contribution of the mother’s milk microbiome in the establishment of the child’s gastrointestinal microbiome and its modulating effect on the child’s immune system, it is determinant to avoid the disruption of milk microbiome that could alter the microbial balance, especially during the first 100 days of life [55]. However, it is important to take into consideration, the fact that pathogens can be transmitted from the mother to the child through breastfeeding. Indeed, viruses like human immunodeficiency virus, human papillomaviruses, Epstein Barr virus, cytomegalovirus, Human T-lymphotropic virus type 1, and Ebolavirus are pathogens that can be vertically transmitted from mothers to their breastfed children [58]-[60]. It is therefore recommended to stop breastfeeding when these pathogens are diagnosed.

However, recommendations regarding breastfeeding differ depending on the type of infection, maternal treatment, and clinical context, and should be guided by international guidelines and a careful assessment of risks and benefits [6] [61] [62].

3.1.7. MicroRNAs in Human Breast Milk

Epigenetic phenomena perform in a filigree manner a governance activity supervising a very wide range of metabolic reactions through mechanisms including histone modifications (acetylation, phosphorylation, methylation, and ubiquitylation), DNA folding, DNA methylation, acetylation, non-coding RNA such as microRNAs, etc… The epigenome is established early before birth, but it is regulated throughout the whole life with modifications and adaptations related to the age and the environment [63].

It appears that infants’ epigenetic reactions could be influenced and potentially modulated or regulated through HBM. One of the most documented pathways of infant’s epigenetics regulation is through microRNAs that have been shown to be present in an abundant amount in breast milk [64]. Despite the fact that these microRNAs are exogenous to the infant, it is hypothesized that these small oligonucleotides may be absorbed by the infant’s cells given that microRNAs are well known to be transferable from one cell to another in cell-to-cell communications or delivered through exosomes [65]. It is therefore possible that these microRNA observed in the milk may be absorbed by infant’s cells and may exert their posttranscriptional regulation effect. However, direct evidence of their functional uptake and epigenetic effects in human infants remains limited [66]. It has been shown that the microRNA composition in the milk depends on several factors including mother’s diet, maternal age, race, parity, mother’s metabolic condition such as body mass index, gestational diabetes [67]. Overall, it is suggested that breast feeding may be also a way for the mother to transmit her epigenomic reactions to the infant.

The precise role of these breast milk containing microRNAs are not well known but it is established that they may play an essential role in the maturation of the immune system in infants, may protect against several pathogens by inhibiting their replication and also may help in shaping intestinal epithelial cells [35] [68]. In addition, some miRNAs may play a role in remodeling immune responses against microbial infections [69]. There is increasing interest in their potential ability to be transferred to offspring, as well as their specific involvement in the benefits of breast milk in the infant [70] [71].

3.2. Dynamics in the Composition of Breast Milk

With its unique composition of nutritional elements, immune and anti-infective factors, and enzymes, HBM covers the crucial developmental needs of early life [26]. Colostrum is the initial milk secreted by the mammary glands immediately after delivery, and is distinct in appearance, composition, and volume. The first days postpartum, colostrum appears typically thick with a yellow hue and is produced in low quantities [72]. Colostrum is recognized for its role in building up and strengthening the immune system of the newborn. In addition to its rich content in energy, minerals and vitamins, colostrum contains several antibodies. Colostrum also contains a substantial quantity of proteins, directly assimilable sugars (oligosaccharides), vitamins, minerals, and amino acids [72] [73]. Following this initial period, the secretory activation phase ensues, which is characterized by a “milk rush”. This results in the mammary glands producing milk in greater volume [74]. This transitional milk, which is white-orange in color and less dense, is particularly rich in sugars and fats. It is considered that maternal milk is fully mature around one month after delivery [75]. This milk is designated as mature due to its relatively stable composition at this stage, despite continued influence from various parameters [74]. As the infant develops, the volume of milk produced continues to increase. Its composition then corresponds to the infant’s age and needs. The quantity and quality of breast milk vary according to the mother’s daily diet [76]. Despite the variability in composition, breast milk remains an optimal source of nutrition for infants, providing the nutrients and protective factors necessary for their growth and development.

3.3. Effect of Breastfeeding on Infants and Maternal Health

Newborns are recommended to be breastfed within one hour after birth and be exclusively breastfed for the first six months of life. Exclusive breastfeeding means that infants receive only breast milk, without any additional food or liquid, including water [7] [77]. It is now well documented that the consumption of water, herbal teas, porridges, and solid foods by infants under 6 months carries an elevated risk of diarrhea morbidity and mortality [78]. Globally, enhanced breastfeeding practices could prevent deaths of thousands of children annually, with over half of these deaths occurring in infants under six months of age [79].

Apart from being advantageous to infants’ wellbeing, exclusive breastfeeding has many benefits for the physical and emotional health of mothers as it strengthens the mother—child emotional bonds, and helps mothers to recover and prevent bleeding [80] [81]. Furthermore, it delays the resume of menstrual cycle, improves uterine involution, reduces the risk of postpartum depression by regulating cortisol circadian rhythms, and reduces the risk of breast and ovarian cancers [82]-[85]. Moreover, research has demonstrated that mothers who choose to breastfeed tend to lose more weight and present reduced risk of type 2 diabetes, cardiovascular diseases, and metabolic syndrome [86] [87].

3.4. Breastfeeding and the Double Burden of Malnutrition

Exclusive breastfeeding (EBF) is increasingly recognized as a key early childhood intervention to address the double burden of malnutrition (DBM), defined as the coexistence of undernutrition, micronutrient deficiencies and overweight/obesity over the life course. These different forms of malnutrition are interconnected by complex mechanisms operating throughout the life cycle, from infancy to adulthood [88].

EBF significantly reduces the incidence and severity of infections, particularly diarrheal and respiratory diseases, through the transfer of immunoglobulins, human milk oligosaccharides, and other bioactive factors. This protection reduces nutritional losses, preserves the integrity of the intestinal mucosa, and improves nutrient absorption, thereby breaking the vicious cycle of infection-malnutrition, the primary determinant of stunting and micronutrient deficiencies [89]. Exclusive breastfeeding also plays a key role in metabolic programming. With its specific composition and bioactive factors, breast milk modulates insulin sensitivity, adipocyte differentiation, and satiety signals. These mechanisms are particularly important in contexts where early undernutrition is followed by exposure to high-calorie diets, leading to the emergence of the double burden of malnutrition [88]. Meta-analyses conducted in this context show that exclusive breastfeeding and its duration are associated with a significant reduction in the risk of overweight and obesity in children [90] [91]. Exclusive breastfeeding influences later eating habits as well as behavioral regulation of energy intake. Breastfed infants are more likely to develop the ability to self-regulate hunger and satiety than bottle-fed infants, who are at higher risk of overeating. Furthermore, exclusive breastfeeding is associated with a more appropriate introduction of complementary foods, both in terms of timing and nutritional quality, which limits early exposure to ultra-processed and energy-dense foods. Longitudinal studies also indicate that exclusive breastfeeding for at least the first six months is associated with a reduced risk of overweight and obesity through adolescence and into early adulthood [92]. Furthermore, recent data suggest that suboptimal infant feeding practices may simultaneously increase the risk of undernutrition and overweight, thereby illustrating the central role of nutrition during the first 1,000 days of life in the development of DBM. For example, cohort studies have shown that not breastfeeding is associated with an increased risk of underweight and obesity during early childhood [93].

3.5. Epidemiology of Exclusive Breastfeeding

Breastfeeding can take many forms, depending on medical indications, the mother’s personal preferences or contextual constraints (Figure 1). Although exclusive breastfeeding is recommended as the optimal feeding standard for infants under 6 months, its practice varies considerably around the world and constitutes a complex area of study due to multiple factors that can modulate its practice.

Figure 1. Type of breastfeeding.

At the global level, exclusive breastfeeding for infants under 6 months of age is practiced in ranges around 48% with low- and middle income countries showing the highest levels [94]. Variations in exclusive breastfeeding rates can be attributed to cultural, socioeconomic, educational, and health practices factors. Table 2 shows the rates of exclusive breastfeeding practice in 202 countries [95].

Table 2. Prevalence of exclusive breastfeeding in 2025 around the world.

Continents

Countries

Study Year

EBF Rate (%)

Evaluation Method

AFRICA

Algeria

2019

28.6

MICS

Angola

2015

37.4

DHS

Benin

2018

41.4

DHS

Botswana

2017

30

Other

Burkina Faso

2021

51.3

DHS

Burundi

2022

85

SMART

Cabo Verde

2018

41.8

DHS-Style

Cameroon

2018

39.4

DHS

Central African Republic

2019

36.2

MICS

Chad

2022

7.4

SMART

Comoros

2022

22.6

MICS

Congo

2014

32.9

MICS

Cote d’Ivoire

2021

34

DHS

Democratic Republic of the Congo

2023

52.5

DHS

Djibouti

2012

12.4

PAPFAM

Egypt

2021

40.2

DHS-Style

Equatorial Guinea

2011

7.4

DHS

Eritrea

2010

68.7

Other

Eswatini

2021

54

MICS

Ethiopia

2019

58.8

IDHS

Gabon

2020

19.4

DHS

Gambia

2020

53.6

DHS

Ghana

2022

52.6

DHS

Guinea

2022

43.7

SMART

Guinea-Bissau

2019

59.3

MICS

Kenya

2022

59.7

DHS

Lesotho

2024

60.7

DHS

Liberia

2019

55.2

DHS

Madagascar

2021

54.4

DHS

Malawi

2020

64.1

MICS

Mali

2024

40.3

DHS

Mauritania

2020

40.9

DHS

Morocco

2017

35

PAPFAM

AFRICA

Mozambique

2022

55.5

DHS

Namibia

2013

48.3

DHS

Niger

2022

24.5

SMART

Nigeria

2024

28.8

DHS

Rwanda

2020

80.9

DHS

Sao Tome and Principe

2019

63.1

MICS

Senegal

2023

34.4

CDHS

Sierra Leone

2021

50.9

SMART

Somalia

2018

33.7

DHS-Style

South Africa

2016

31.6

DHS

South Sudan

2010

44.5

MICS

Sudan

2014

54.6

MICS

Togo

2017

64.3

MICS

Tunisia

2018

13.5

MICS

Uganda

2016

65.5

DHS

Zambia

2024

64.1

DHS

Zimbabwe

2024

42.4

DHS

ASIA

Afghanistan

2022

63.3

MICS

Armenia

2016

44.5

DHS

Azerbaijan

2023

18.4

MICS

Bangladesh

2022

53.3

DHS

Bhutan

2015

53.2

NNS

Cambodia

2021

50.3

DHS

China

2017

35.1

Other

Democratic People’s Republic of Korea

2017

71.4

MICS

Georgia

2018

20.4

MICS

India

2020

63.7

DHS

Indonesia

2017

50.7

DHS

Iran (Islamic Republic of)

2017

47.4

NNS

Iraq

2018

25.8

MICS

Jordan

2023

23.9

DHS

Kazakhstan

2015

37.8

MICS

Kyrgyzstan

2018

45.6

MICS

Lao People’s Democratic Republic

2023

50.6

MICS

Lebanon

2023

22.7

NNS

Malaysia

2016

40.3

Other

Maldives

2017

63

DHS

ASIA

Mongolia

2023

51.1

MICS

Myanmar

2016

51.2

DHS

Nepal

2022

56.4

DHS

Oman

2017

23.2

NNS

Pakistan

2018

47.8

NNS

Philippines

2022

40.9

DHS

Qatar

2012

29.3

MICS

Sri Lanka

2016

80.9

DHS-Style

State of Palestine

2020

38.9

MICS

Syrian Arab Republic

2019

28.5

SMART

Tajikistan

2023

40.8

DHS

Thailand

2022

28.6

MICS

Timor-Leste

2020

65

NNS

Turkmenistan

2019

56.5

MICS

Türkiye

2018

40.7

DHS-Style

Uzbekistan

2021

25.2

MICS

Viet Nam

2020

45.4

MICS

Yemen

2013

9.7

DHS

EUROPE

Albania

2017

36.5

DHS

Belarus

2019

21.7

MICS

Bosnia and Herzegovina

2012

18.2

MICS

Croatia

1996

23.5

MICS

Montenegro

2018

19.5

MICS

North Macedonia

2019

27.5

MICS

Republic of Moldova

2012

36.4

MICS

Romania

2004

15.8

RHS

Serbia

2019

23.6

MICS

Ukraine

2012

19.7

MICS

NORTHERN AMERICA; LATIN AMERICA AND THE CARIBBEAN

Argentina

2011

32

MICS

Barbados

2012

19.7

MICS

Belize

2015

33.2

MICS

Bolivia (Plurinational State of)

2016

55.7

DHS-Style

Brazil

2019

45.8

NNS

Colombia

2016

36.7

NNS

Costa Rica

2018

25.3

MICS

Cuba

2019

40.6

MICS

Dominican Republic

2019

15.8

MICS

NORTHERN AMERICA; LATIN AMERICA AND THE CARIBBEAN

Ecuador

2004

39.6

RHS

El Salvador

2021

45.3

Other

Guatemala

2021

58.5

NNS

Guyana

2019

28.5

MICS

Haiti

2017

39.9

DHS

Honduras

2019

30.2

MICS

Jamaica

2022

33

MICS

Mexico

2021

35.9

Other

Nicaragua

2012

31.7

Other

Panama

2013

21.5

MICS

Paraguay

2016

29.6

MICS

Peru

2023

70.1

DHS-Style

Saint Lucia

2012

3.5

MICS

Suriname

2018

8.9

MICS

Trinidad and Tobago

2022

30.5

MICS

Turks and Caicos Islands

2020

-

MICS

United States

2018

25.8

NHANES

Uruguay

2018

57.7

Other

Venezuela (Bolivarian Republic of)

1998

7.1

Other

OCEANIA

Fiji

2021

42.9

MICS

Kiribati

2018

63.6

MICS

Marshall Islands

2017

43.1

MICS-Style

Nauru

2007

67.2

DHS-Style

Papua New Guinea

2017

59.7

DHS

Samoa

2019

51.7

MICS

Solomon Islands

2015

76.2

DHS-Style

Tonga

2019

39.6

MICS

Tuvalu

2019

43.8

MICS

Vanuatu

2023

75.9

MICS

3.6. Factors Limiting the Practice of Exclusive Breastfeeding

Despite its numerous advantages, exclusive breastfeeding encounters several obstacles in its applicability. Indeed, number of factors including sociodemographic and individual factors, access to care, beliefs, perceptions, education and social norms can limit mothers in their adoption of exclusive breastfeeding [96]. One of the most impactful limiting factors is the lack of information about exclusive breastfeeding but the professional obligations lead many mothers to abandon this practice. In addition, several mothers reported their fear to undergo morphological changes such as breast ptosis related to breastfeeding. Mothers who work in public sometimes feel an embarrassment to breastfeed their infants leading them to opt for partial breastfeeding instead. This factor underlines the necessity to provide appropriate space for breastfeeding in public spaces and at work [97].

Mothers that do not exclusively breastfeed their infants have also pointed the delay in lactation, the production of insufficient amount of milk, breast pain and abscesses, twin pregnancies as obstacles to breastfeeding [98]. Availability of milk substitutes in some regions, especially in high-income countries and urban regions in low- and middle-income countries constitute a limiting factor to breastfeeding. Moreover, the use of substitutes is considered as modern in some regions [99] [100].

All these mentioned limiting factors show that interventions to improve the level of exclusive breastfeeding practice should take into consideration several aspects of mothers’ life as well as social influence persons in addition to information sessions provided only to mothers

3.7. Methods for Assessing Exclusive Breastfeeding

The most commonly used method for the assessment of exclusive breastfeeding rates is the 24-hour recall. It consists on questioning mothers about all foods and liquids given to their infants in the previous 24 hours. In these surveys, a child is considered exclusively breastfed only if no food or liquid (including water) other than breast milk was consumed during the recall period [95]. The questionnaire approach is subject to social desirability bias which can be minimized by using additional evaluations such as anthropometry. Another limitation of the data produced by breastfeeding assessment surveys is the absence of a database on the amount of milk consumed by babies and the nutritional status of mothers. Furthermore, determining the amount of milk consumed by an infant is a methodological challenge. The conventional method for quantifying milk consumption is the differential weighing by measuring the weight of infants before and after each feeding. This method is time-consuming and can disrupt breastfeeding in addition to being an imprecise method of assessing milk intake in infants [101].

Evolutions in nuclear sciences allowed the development of a more robust method to measure milk intake. The method is based on the administration of deuterium to the mother and the quantification of the stable isotope tracer in infant’s biologic fluids (saliva or urine). The method relies on the fact that the absorbed deuterium is diluted in the mother’s body water including milk. During breastfeeding, the infant absorbs the deuterium which will also get diluted in the infant’s water compartment so that, quantifying this deuterium in the infant’s saliva or urine provides precise data on the quantity of consumed milk [102]. After several test studies, this method is now well established as a robust tool for the assessment of daily milk intake [103] [104]. In addition to providing quantitative data on consumed milk, the isotopic technique can also provide qualitative data on consumed milk. Indeed, it could help obtain data regarding the content of some nutrients as well as some toxic compounds including pesticides or trace elements [105] [106].

The isotopic technique does not interfere with the infant’s normal feeding schedule and allows for the estimation of the amount of water consumed by the infant, thus excluding water from sources other than breast milk and the mother’s body composition. Its preciseness makes it the best tool to evaluate implementation programs and confirm the data obtained using the conventional 24 h recall [107]. It is important to mention that mothers have been shown to significantly overestimate their practice of exclusive breastfeeding whereas the deuterium dilution technique provides more precise data. Furthermore, this technique provides data on mothers’ body composition as well as the influence of the body composition of these mothers on the quantity of breast milk consumed by their infants.

The availability of the IAIE database on breast milk intake that gathers data from around world obtained using this method increases the relevance of this technique as it allows better epidemiologic studies [108]. The method presents some limitations especially for its application in large scale studies in low- and middle-income countries where it is difficult to have access to deuterium oxide and equipment for its quantification. Among the two applicable platforms for deuterium quantification, the Fourier transform infrared spectrometry (FTIR) represents the most accessible and easily implementable system in comparison to isotopic mass spectrometry [109]. Overall, isotopic methods provide accurate results on water consumption from milk and other sources and mother’s body composition. The technique generates a lot of data that can be used to evaluate breastfeeding practice but also the nutritional status of both mother and infant.

Different methods can be used to assess exclusive breastfeeding (EBF), depending on the objective of the evaluation. The 24-hour recall method is widely used in large-scale surveys and routine surveillance due to its simplicity, low cost and minimal logistical requirements, which make it suitable for population-level monitoring [110]-[112]. However, it may overestimate EBF prevalence because it only captures recent feeding practices [111] [113] [114].

In contrast, isotopic techniques, such as the deuterium oxide dose-to-mother method, provide a more objective, quantitative assessment of breast milk intake over a defined period and can identify non-breast milk water intake [112] [115] [116]. These methods are particularly valuable in research settings and program evaluations where precise measurement is required.

From an operational perspective, the 24-hour recall method requires trained interviewers and standardized questionnaires, whereas isotopic methods require specialized training, controlled dosing procedures, repeated sample collection over several days and access to laboratory infrastructure for isotope analysis [112] [115]. Therefore, the choice of method should balance accuracy needs with feasibility, resources, and the intended use of the data.

4. Conclusions

HBM is a dynamic nutritious food that is formed with the intend to provide infants with all they need for proper development. Given its composition, this milk is not only a source of nutrients for infants, it is also an ideal route by which mothers continue to physiologically take care of their infants by helping in establishing the immune system and initiating epigenetic regulation as well as microbiome functions.

Given these advantages, exclusive breastfeeding during the first six months after birth is a relevant recommendation and national public health authorities should incorporate it in their priority actions. Exclusive breast feeding should therefore be evaluated regularly in order to shape public health strategies for effective outcomes, at least regarding the health of under five years old infants. This evaluation needs to be precise, non-invasive, cost effective, and minimize bias.

Acknowledgements

Conception and design of the study: MEK, TS./Acquisition of data: MEK, TS, DB./Data analysis and interpretation: MEK, TS, DB, EKA, EC, AEA, SKA./Article writing: MEK, TS, DB, EKA, EC, AEA, SKA./All authors read and approved the final version of this manuscript.

Conflicts of Interest

The authors declare no competing interests.

References

[1] Clark, H., Coll-Seck, A.M., Banerjee, A., Peterson, S., Dalglish, S.L., Ameratunga, S., et al. (2020) A Future for the World’s Children? A WHO-UNICEF-Lancet Commission. The Lancet, 395, 605-658.[CrossRef] [PubMed]
[2] Lu, C., Black, M.M. and Richter, L.M. (2016) Risk of Poor Development in Young Children in Low-Income and Middle-Income Countries: An Estimation and Analysis at the Global, Regional, and Country Level. The Lancet Global Health, 4, e916-e922.[CrossRef] [PubMed]
[3] Stein, A.D., Adair, L.S., Donati, G., Wray, C., Richter, L.M., Norris, S.A., et al. (2023) Early-Life Stature, Preschool Cognitive Development, Schooling Attainment, and Cognitive Functioning in Adulthood: A Prospective Study in Four Birth Cohorts. The Lancet Global Health, 11, e95-e104.[CrossRef] [PubMed]
[4] WHO (2009) Infant and Young Child Feeding: Model Chapter for Textbooks for Medical Students and Allied Health Professionals. World Health Organization.
[5] Pérez-Escamilla, R., Tomori, C., Hernández-Cordero, S., Baker, P., Barros, A.J.D., Bégin, F., et al. (2023) Breastfeeding: Crucially Important, but Increasingly Challenged in a Market-Driven World. The Lancet, 401, 472-485.[CrossRef] [PubMed]
[6] Victora, C.G., Bahl, R., Barros, A.J.D., França, G.V.A., Horton, S., Krasevec, J., et al. (2016) Breastfeeding in the 21st Century: Epidemiology, Mechanisms, and Lifelong Effect. The Lancet, 387, 475-490.[CrossRef] [PubMed]
[7] WHO (2022) Infant and Young Child Feeding.
https://www.who.int/news-room/fact-sheets/detail/infant-and-young-child-feeding
[8] UNICEF (2011) Programming Guide. Infant and Young Child Feeding.
https://dev.nutritioncluster.net/sites/nutritioncluster.com/files/2020-01/Final_IYCF_prog_guide_May_26_2011.pdf
[9] Lee, H., Padhi, E., Hasegawa, Y., Larke, J., Parenti, M., Wang, A., et al. (2018) Compositional Dynamics of the Milk Fat Globule and Its Role in Infant Development. Frontiers in Pediatrics, 6, Article 313.[CrossRef] [PubMed]
[10] Sala-Vila, A., Castellote, A.I., Rodriguez-Palmero, M., Campoy, C. and López-Sabater, M.C. (2005) Lipid Composition in Human Breast Milk from Granada (Spain): Changes during Lactation. Nutrition, 21, 467-473.[CrossRef] [PubMed]
[11] Bardanzellu, F., Peroni, D.G. and Fanos, V. (2020) Human Breast Milk: Bioactive Components, from Stem Cells to Health Outcomes. Current Nutrition Reports, 9, 1-13.[CrossRef] [PubMed]
[12] Lönnerdal, B. (2004) Human Milk Proteins: Key Components for the Biological Activity of Human Milk. In: Advances in Experimental Medicine and Biology, Springer, 11-25.[CrossRef
[13] Molinari, C.E., Casadio, Y.S., Hartmann, B.T., Livk, A., Bringans, S., Arthur, P.G., et al. (2012) Proteome Mapping of Human Skim Milk Proteins in Term and Preterm Milk. Journal of Proteome Research, 11, 1696-1714.[CrossRef] [PubMed]
[14] Meng, F., Uniacke-Lowe, T., Ryan, A.C. and Kelly, A.L. (2021) The Composition and Physico-Chemical Properties of Human Milk: A Review. Trends in Food Science & Technology, 112, 608-621.[CrossRef
[15] Li, X., Zhang, X., Zhang, M., Liu, X., Gao, Z., Zhao, J., et al. (2025) Human Milk Whey Proteins: Constituents, Influencing Factors, Detection Methods, and Comparative Analysis with Other Sources. Food Chemistry: X, 25, Article 102082.[CrossRef] [PubMed]
[16] Donovan, S.M. (2019) Human Milk Proteins: Composition and Physiological Significance. In: Nestlé Nutrition Institute Workshop Series, S. Karger AG, 93-101.[CrossRef] [PubMed]
[17] Lönnerdal, B. (2016) Bioactive Proteins in Human Milk: Health, Nutrition, and Implications for Infant Formulas. The Journal of Pediatrics, 173, S4-S9.[CrossRef] [PubMed]
[18] Witkowska-Zimny, M. and Kaminska-El-Hassan, E. (2017) Cells of Human Breast Milk. Cellular & Molecular Biology Letters, 22, 1-11.[CrossRef] [PubMed]
[19] Plaza-Díaz, J., Fontana, L. and Gil, A. (2018) Human Milk Oligosaccharides and Immune System Development. Nutrients, 10, Article 1038.[CrossRef] [PubMed]
[20] Kunz, C., Rudloff, S., Baier, W., Klein, N. and Strobel, S. (2000) Oligosaccharides in Human Milk: Structural, Functional, and Metabolic Aspects. Annual Review of Nutrition, 20, 699-722.[CrossRef] [PubMed]
[21] Cheng, L., Akkerman, R., Kong, C., Walvoort, M.T.C. and de Vos, P. (2021) More than Sugar in the Milk: Human Milk Oligosaccharides as Essential Bioactive Molecules in Breast Milk and Current Insight in Beneficial Effects. Critical Reviews in Food Science and Nutrition, 61, 1184-1200.[CrossRef] [PubMed]
[22] Schwertmann, A., Schroten, H., Hacker, J. and Kunz, C. (1999) S-Fimbriae from Escherichia Coli Bind to Soluble Glycoproteins from Human Milk. Journal of Pediatric Gastroenterology & Nutrition, 28, 257-263.[CrossRef] [PubMed]
[23] Varki, A. (1993) Biological Roles of Oligosaccharides: All of the Theories Are Correct. Glycobiology, 3, 97-130.[CrossRef] [PubMed]
[24] Dinleyici, M., Barbieur, J., Dinleyici, E.C. and Vandenplas, Y. (2023) Functional Effects of Human Milk Oligosaccharides (HMOs). Gut Microbes, 15, Article 2186115. [Google Scholar] [CrossRef] [PubMed]
[25] Koletzko, B., Rodriguez-Palmero, M., Demmelmair, H., Fidler, N., Jensen, R. and Sauerwald, T. (2001) Physiological Aspects of Human Milk Lipids. Early Human Development, 65, S3-S18.[CrossRef] [PubMed]
[26] Andreas, N.J., Kampmann, B. and Mehring Le-Doare, K. (2015) Human Breast Milk: A Review on Its Composition and Bioactivity. Early Human Development, 91, 629-635.[CrossRef] [PubMed]
[27] Garwolińska, D., Namieśnik, J., Kot-Wasik, A. and Hewelt-Belka, W. (2018) Chemistry of Human Breast Milk—A Comprehensive Review of the Composition and Role of Milk Metabolites in Child Development. Journal of Agricultural and Food Chemistry, 66, 11881-11896.[CrossRef] [PubMed]
[28] Vaysse, C., Billeaud, C., Guesnet, P., Couëdelo, L., Alessandri, J.M., Putet, G., et al. (2011) Teneurs en acides gras polyinsaturés essentiels du lait maternel en France: Évolution des teneurs en acides linoléique et alpha-linolénique. Médecine & Nutrition, 47, 5-9.[CrossRef
[29] Ballard, O. and Morrow, A.L. (2013) Human Milk Composition: Nutrients and Bioactive Factors. Pediatric Clinics, 60, 49-74.
[30] Tanaka, K., Hosozawa, M., Kudo, N., Yoshikawa, N., Hisata, K., Shoji, H., et al. (2013) The Pilot Study: Sphingomyelin-Fortified Milk Has a Positive Association with the Neurobehavioural Development of Very Low Birth Weight Infants during Infancy, Randomized Control Trial. Brain and Development, 35, 45-52.[CrossRef] [PubMed]
[31] Hamdan, I.J.A., Sanchez-Siles, L.M., Matencio, E., Garcia-Llatas, G. and Lagarda, M.J. (2018) Cholesterol Content in Human Milk during Lactation: A Comparative Study of Enzymatic and Chromatographic Methods. Journal of Agricultural and Food Chemistry, 66, 6373-6381.[CrossRef] [PubMed]
[32] Ni, X., Zhang, Z., Deng, Z., Duan, S., Szeto, I.M., He, J., et al. (2025) Global Levels and Variations of Cholesterol and Polar Lipids of Human Milk: A Systematic Review and Meta-Analysis. Journal of Agricultural and Food Chemistry, 73, 7046-7064.[CrossRef] [PubMed]
[33] Li, C., Solomons, N.W., Scott, M.E. and Koski, K.G. (2016) Minerals and Trace Elements in Human Breast Milk Are Associated with Guatemalan Infant Anthropometric Outcomes within the First 6 Months. The Journal of Nutrition, 146, 2067-2074.[CrossRef] [PubMed]
[34] FAO (1998) Human Vitamin and Mineral Requirements: Report of a Joint FAO/WHO Expert Consultation (FAO Food and Nutrition Series No. 77). FAO.
https://www.fao.org/3/y2809e/y2809e00.htm
[35] Kim, S.Y. and Yi, D.Y. (2020) Components of Human Breast Milk: From Macronutrient to Microbiome and MicroRNA. Clinical and Experimental Pediatrics, 63, 301-309.[CrossRef] [PubMed]
[36] Khayat, S., Fanaei, H. and Ghanbarzehi, A. (2017) Minerals in Pregnancy and Lactation: A Review Article. Journal of Clinical and Diagnostic Research, 11, QE01.
[37] Zhang, H., Ren, X., Yang, Z. and Lai, J. (2022) Vitamin a Concentration in Human Milk: A Meta-Analysis. Nutrients, 14, Article 4844.[CrossRef] [PubMed]
[38] Xi, Y., Wang, X., Liu, K., Zhang, H., Ren, X., Zhao, A., et al. (2022) Vitamin E Concentration in Breast Milk in Different Periods of Lactation: Meta-Analysis. Frontiers in Nutrition, 9, Article 1050011.[CrossRef] [PubMed]
[39] Kratzsch, J., Bae, Y.J. and Kiess, W. (2018) Adipokines in Human Breast Milk. Best Practice & Research Clinical Endocrinology & Metabolism, 32, 27-38.[CrossRef] [PubMed]
[40] Mazzocchi, A., Giannì, M.L., Morniroli, D., Leone, L., Roggero, P., Agostoni, C., et al. (2019) Hormones in Breast Milk and Effect on Infants’ Growth: A Systematic Review. Nutrients, 11, Article 1845.[CrossRef] [PubMed]
[41] Savino, F., Liguori, S.A., Fissore, M.F. and Oggero, R. (2009) Breast Milk Hormones and Their Protective Effect on Obesity. International Journal of Pediatric Endocrinology, 2009, 1-8.[CrossRef] [PubMed]
[42] Suwaydi, M.A., Gridneva, Z., Perrella, S.L., Wlodek, M.E., Lai, C.T. and Geddes, D.T. (2021) Human Milk Metabolic Hormones: Analytical Methods and Current Understanding. International Journal of Molecular Sciences, 22, Article 8708.[CrossRef] [PubMed]
[43] Ilcol, Y.O., Hizli, Z.B. and Ozkan, T. (2006) Leptin Concentration in Breast Milk and Its Relationship to Duration of Lactation and Hormonal Status. International Breastfeeding Journal, 1, 1-9.
[44] Savino, F., Costamagna, M., Prino, A., Oggero, R. and Silvestro, L. (2002) Leptin Levels in Breast-Fed and Formula-Fed Infants. Acta Paediatrica, 91, 897-902.[CrossRef
[45] Palou, M., Picó, C. and Palou, A. (2018) Leptin as a Breast Milk Component for the Prevention of Obesity. Nutrition Reviews, 76, 875-892.[CrossRef] [PubMed]
[46] Picó, C. and Palou, M. (2021) Leptin and Metabolic Programming. Nutrients, 14, Article 114.[CrossRef] [PubMed]
[47] Scherer, P.E., Williams, S., Fogliano, M., Baldini, G. and Lodish, H.F. (1995) A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes. Journal of Biological Chemistry, 270, 26746-26749.[CrossRef] [PubMed]
[48] Aydin, S., Aydin, S., Ozkan, Y. and Kumru, S. (2006) Ghrelin Is Present in Human Colostrum, Transitional and Mature Milk. Peptides, 27, 878-882.[CrossRef] [PubMed]
[49] Wren, A.M. (2001) Ghrelin Enhances Appetite and Increases Food Intake in Humans. Journal of Clinical Endocrinology & Metabolism, 86, 5992-5992.[CrossRef] [PubMed]
[50] Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., et al. (2001) The Hormone Resistin Links Obesity to Diabetes. Nature, 409, 307-312.[CrossRef] [PubMed]
[51] Cho, G.J., Yoo, S.W., Hong, S.C., Oh, M., Kim, T., Kim, H.J., et al. (2006) Correlations between Umbilical and Maternal Serum Resistin Levels and Neonatal Birth Weight. Acta Obstetricia et Gynecologica Scandinavica, 85, 1051-1056.[CrossRef] [PubMed]
[52] Klagsbrun, M. (1978) Human Milk Stimulates DNA Synthesis and Cellular Proliferation in Cultured Fibroblasts. Proceedings of the National Academy of Sciences, 75, 5057-5061.[CrossRef] [PubMed]
[53] Elmlinger, M.W., Hochhaus, F., Loui, A., Frommer, K.W., Obladen, M. and Ranke, M.B. (2007) Insulin-Like Growth Factors and Binding Proteins in Early Milk from Mothers of Preterm and Term Infants. Hormone Research in Paediatrics, 68, 124-131.[CrossRef] [PubMed]
[54] Froń, A. and Orczyk-Pawiłowicz, M. (2023) Understanding the Immunological Quality of Breast Milk in Maternal Overweight and Obesity. Nutrients, 15, Article 5016.[CrossRef] [PubMed]
[55] Notarbartolo, V., Giuffrè, M., Montante, C., Corsello, G. and Carta, M. (2022) Composition of Human Breast Milk Microbiota and Its Role in Children’s Health. Pediatric Gastroenterology, Hepatology & Nutrition, 25, 194-210.[CrossRef] [PubMed]
[56] Dombrowska-Pali, A., Wiktorczyk-Kapischke, N., Chrustek, A., Olszewska-Słonina, D., Gospodarek-Komkowska, E. and Socha, M.W. (2024) Human Milk Microbiome—A Review of Scientific Reports. Nutrients, 16, Article 1420.[CrossRef] [PubMed]
[57] Demmelmair, H., Jiménez, E., Collado, M.C., Salminen, S. and McGuire, M.K. (2020) Maternal and Perinatal Factors Associated with the Human Milk Microbiome. Current Developments in Nutrition, 4, nzaa027.[CrossRef] [PubMed]
[58] Stagno, S. and Cloud, G.A. (1994) Working Parents: The Impact of Day Care and Breast-Feeding on Cytomegalovirus Infections in Offspring. Proceedings of the National Academy of Sciences, 91, 2384-2389.[CrossRef] [PubMed]
[59] Glenn, W.K., Whitaker, N.J. and Lawson, J.S. (2012) High Risk Human Papillomavirus and Epstein Barr Virus in Human Breast Milk. BMC Research Notes, 5, Article No. 477.[CrossRef] [PubMed]
[60] Sissoko, D., Keïta, M., Diallo, B., Aliabadi, N., Fitter, D.L., Dahl, B.A., et al. (2017) Ebola Virus Persistence in Breast Milk after No Reported Illness: A Likely Source of Virus Transmission from Mother to Child. Clinical Infectious Diseases, 64, 513-516.[CrossRef] [PubMed]
[61] WHO (2016) Guideline: Updates on HIV and Infant Feeding. World Health Organization.
https://iris.who.int/server/api/core/bitstreams/3ade44b1-647c-462d-9ac2-3f4e3dd874a8/content
[62] WHO (2009) Infant and Young Child Feeding: Model Chapter for Textbooks for Medical Students and Allied Health Professionals. WHO Library Cataloguingin Publication Data.
https://pubmed.ncbi.nlm.nih.gov/23905206/
[63] la Torre, A., Lo Vecchio, F. and Greco, A. (2023) Epigenetic Mechanisms of Aging and Aging-Associated Diseases. Cells, 12, Article 1163.[CrossRef] [PubMed]
[64] Hatmal, M.M., Al-Hatamleh, M.A.I., Olaimat, A.N., Alshaer, W., Hasan, H., Albakri, K.A., et al. (2022) Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. Biomedicines, 10, Article 1219.[CrossRef] [PubMed]
[65] Arefimehr, R. and Ahmad, A. (2026) Exosomal MicroRNAs: From Cellular Communication to Disease Biomarkers. International Immunopharmacology, 173, Article 116328.[CrossRef
[66] Słyk-Gulewska, P., Kondracka, A. and Kwaśniewska, A. (2023) Microrna as a New Bioactive Component in Breast Milk. Non-Coding RNA Research, 8, 520-526.[CrossRef] [PubMed]
[67] Hicks, S.D., Confair, A., Warren, K. and Chandran, D. (2022) Levels of Breast Milk MicroRNAs and Other Non-Coding RNAs Are Impacted by Milk Maturity and Maternal Diet. Frontiers in Immunology, 12, Article 785217.[CrossRef] [PubMed]
[68] Kosaka, N., Izumi, H., Sekine, K. and Ochiya, T. (2010) MicroRNA as a New Immune-Regulatory Agent in Breast Milk. Silence, 1, Article No. 7.[CrossRef] [PubMed]
[69] Brockway, M., Daniel, A.I., Reyes, S.M., Gauglitz, J.M., Granger, M., McDermid, J.M., et al. (2024) Human Milk Bioactive Components and Child Growth and Body Composition in the First 2 Years: A Systematic Review. Advances in Nutrition, 15, Article 100127.[CrossRef] [PubMed]
[70] Alsaweed, M., Hartmann, P., Geddes, D. and Kakulas, F. (2015) MicroRNAs in Breastmilk and the Lactating Breast: Potential Immunoprotectors and Developmental Regulators for the Infant and the Mother. International Journal of Environmental Research and Public Health, 12, 13981-14020.[CrossRef] [PubMed]
[71] Carrillo-Lozano, E., Sebastián-Valles, F. and Knott-Torcal, C. (2020) Circulating MicroRNAs in Breast Milk and Their Potential Impact on the Infant. Nutrients, 12, Article 3066.[CrossRef] [PubMed]
[72] de Vries, J., Pundir, S., Mckenzie, E., Keijer, J. and Kussmann, M. (2018) Maternal Circulating Vitamin Status and Colostrum Vitamin Composition in Healthy Lactating Women—A Systematic Approach. Nutrients, 10, Article 687.[CrossRef] [PubMed]
[73] de Siqueira, C.D., Borges, L., Dal Mora, T., Saleh, N.A., Alves, E.S., Wopereis, S., et al. (2025) Early Postnatal Effects of Maternal Obesity on Breast Milk Composition and Breastfeeding Outcomes. Clinical Nutrition ESPEN, 65, 365-374.[CrossRef] [PubMed]
[74] Dugas, C. (2021) Rôle de l’alimentation dans la prévention des complications associées à une exposition intra-utérine au diabète gestationnel. Université Laval.
[75] Chellala, S. and Kechout, R. (2022) Étude comparative de la qualité nutritionnelle du lait maternel et du lait maternisé (infantile). Université Mouloud Mammeri.
[76] Wu, J., Domellöf, M., Zivkovic, A.M., Larsson, G., Öhman, A. and Nording, M.L. (2016) NMR-Based Metabolite Profiling of Human Milk: A Pilot Study of Methods for Investigating Compositional Changes during Lactation. Biochemical and Biophysical Research Communications, 469, 626-632.[CrossRef] [PubMed]
[77] WHO and UNICEF (2003) Global Strategy for Infant and Young Child Feeding. World Health Organization.
https://iris.who.int/handle/10665/42590
[78] Albernaz, E., Victora, C.G., Haisma, H., Wright, A. and Coward, W.A. (2003) Lactation Counseling Increases Breast-Feeding Duration but Not Breast Milk Intake as Measured by Isotopic Methods. The Journal of Nutrition, 133, 205-210.[CrossRef] [PubMed]
[79] Walters, D.D., Phan, L.T.H. and Mathisen, R. (2019) The Cost of Not Breastfeeding: Global Results from a New Tool. Health Policy and Planning, 34, 407-417.[CrossRef] [PubMed]
[80] Delli Carpini, G., Morini, S., Papiccio, M., Serri, M., Damiani, V., Grelloni, C., et al. (2019) The Association between Childbirth, Breastfeeding, and Uterine Fibroids: An Observational Study. Scientific Reports, 9, Article No. 10117.[CrossRef] [PubMed]
[81] Abedi, P., Jahanfar, S., Namvar, F. and Lee, J. (2016) Breastfeeding or Nipple Stimulation for Reducing Postpartum Haemorrhage in the Third Stage of Labour. Cochrane Database of Systematic Reviews, 2016, CD010845.[CrossRef] [PubMed]
[82] Figueiredo, B., Dias, C.C., Brandão, S., Canário, C. and Nunes-Costa, R. (2013) Breastfeeding and Postpartum Depression: State of the Art Review. Jornal de Pediatria, 89, 332-338.[CrossRef] [PubMed]
[83] Ahn, S. and Corwin, E.J. (2015) The Association between Breastfeeding, the Stress Response, Inflammation, and Postpartum Depression during the Postpartum Period: Prospective Cohort Study. International Journal of Nursing Studies, 52, 1582-1590.[CrossRef] [PubMed]
[84] Rosenblatt, K.A. and Thomas, D.B. (1993) Lactation and the Risk of Epithelial Ovarian Cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. The International Journal of Epidemiology, 22, 192-197.
[85] Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast Cancer and Breastfeeding: Collaborative Reanalysis of Individual Data from 47 Epidemiological Studies in 30 Countries, Including 50 302 Women with Breast Cancer and 96 973 Women without the Disease. The Lancet, 360, 187-195.
[86] Chowdhury, R., Sinha, B., Sankar, M.J., Taneja, S., Bhandari, N., Rollins, N., et al. (2015) Breastfeeding and Maternal Health Outcomes: A Systematic Review and Meta-Analysis. Acta Paediatrica, 104, 96-113.[CrossRef] [PubMed]
[87] Temples, H.S. (2019) Breastfeeding Reduces Risk of Type 2 Diabetes in the (PETS). Nursing Outlook, 67, 115. [Google Scholar] [CrossRef
[88] Wells, J.C., Sawaya, A.L., Wibaek, R., Mwangome, M., Poullas, M.S., Yajnik, C.S., et al. (2020) The Double Burden of Malnutrition: Aetiological Pathways and Consequences for Health. The Lancet, 395, 75-88.[CrossRef] [PubMed]
[89] Hamer, D.H., Solomon, H., Das, G., Knabe, T., Beard, J., Simon, J., et al. (2022) Importance of Breastfeeding and Complementary Feeding for Management and Prevention of Childhood Diarrhoea in Low-and Middle-Income Countries. Journal of Global Health, 12, Article 10011.[CrossRef] [PubMed]
[90] Qiao, J., Dai, L., Zhang, Q. and Ouyang, Y. (2020) A Meta-Analysis of the Association between Breastfeeding and Early Childhood Obesity. Journal of Pediatric Nursing, 53, 57-66.[CrossRef] [PubMed]
[91] Yan, J., Liu, L., Zhu, Y., Huang, G. and Wang, P.P. (2014) The Association between Breastfeeding and Childhood Obesity: A Meta-Analysis. BMC Public Health, 14, Article No. 1267.[CrossRef] [PubMed]
[92] Tambalis, K.D., Mourtakos, S., Panagiotakos, D.B. and Sidossis, L.S. (2018) Association of Exclusive Breastfeeding with Risk of Obesity in Childhood and Early Adulthood. Breastfeeding Medicine, 13, 687-693.[CrossRef] [PubMed]
[93] Li, W., Yuan, J., Wang, L., Qiao, Y., Liu, E., Wang, S., et al. (2022) The Association between Breastfeeding and Childhood Obesity/Underweight: A Population-Based Birth Cohort Study with Repeated Measured Data. International Breastfeeding Journal, 17, Article No. 82.[CrossRef] [PubMed]
[94] UNICEF (2023) Global Breastfeeding Scorecard 2023.
https://www.unicef.org/documents/global-breastfeeding-scorecard-2023
[95] UNICEF (2025) Analysis, Planning and Monitoring. Global UNICEF Global Databases: Infant and Young Child Feeding: Exclusive Breastfeeding.
https://data.unicef.org/topic/nutrition/infant-and-young-child-feeding/
[96] Diop, R.A. and Boye, S. (n.d.) Allaitement en Afrique de l’Ouest et du Centre. UNICEF–IRD.
https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers18-01/010071735.pdf#page=3
[97] Amir, L.H. (2014) Breastfeeding in Public: “You Can Do It?” International Breastfeeding Journal, 9, Article No. 187.[CrossRef] [PubMed]
[98] Nzame, Y., Gahouma, D., Koko, J., et al. (2020) Place of Breastfeeding in Infant Feeding in Libreville: Survey of 501 Mothers. Health Sciences and Disease, 21, 35-40.
[99] Rollins, N.C., Bhandari, N., Hajeebhoy, N., Horton, S., Lutter, C.K., Martines, J.C., et al. (2016) Why Invest, and What It Will Take to Improve Breastfeeding Practices? The Lancet, 387, 491-504.[CrossRef] [PubMed]
[100] Huet, F., Maigret, P., Elias-Billon, I. and Allaert, F.A. (2016) Identification des déterminants cliniques, sociologiques et économiques de la durée de l’allaitement maternel exclusif. Journal de Pédiatrie et de Puériculture, 29, 177-187.[CrossRef
[101] Savenije, O.E.M. and Brand, P.L.P. (2006) Accuracy and Precision of Test Weighing to Assess Milk Intake in Newborn Infants. Archives of Disease in ChildhoodFetal and Neonatal Edition, 91, F330-F332.[CrossRef] [PubMed]
[102] Coward, W.A., Whitehead, R.G., Sawyer, M.B., Prentice, A.M. and Evans, J. (1979) New Method for Measuring Milk Intakes in Breast-Fed Babies. The Lancet, 314, 13-14.[CrossRef] [PubMed]
[103] Lucas, A., Ewing, G., Roberts, S.B. and Coward, W.A. (1987) Measurement of Milk Intake by Deuterium Dilution. Archives of Disease in Childhood, 62, 796-800.[CrossRef] [PubMed]
[104] Fjeld, C., Brown, K. and Schoeller, D. (1988) Validation of the Deuterium Oxide Method for Measuring Average Daily Milk Intake in Infants. The American Journal of Clinical Nutrition, 48, 671-679.[CrossRef] [PubMed]
[105] Limon-Miro, A.T., Aldana-Madrid, M.L., Alvarez-Hernandez, G., Antunez-Roman, L.E., Rodriguez-Olibarria, G. and Valencia Juillerat, M.E. (2017) Breast Milk Intake and Mother to Infant Pesticide Transfer Measured by Deuterium Oxide Dilution in Agricultural and Urban Areas of Mexico. Chemosphere, 181, 682-689.[CrossRef] [PubMed]
[106] Ojo, J. (2018) Determination of Babies’ Intake of Trace Elements through Breastmilk and Mothers’ Nutritional Status in Ile-Ife, Nigeria. International Symposium on Understanding the Double Burden of Malnutrition for Effective Interventions. Book of Abstracts.
https://inis.iaea.org/records/wj0w8-z1k07
[107] Davidsson, L. (2010) Stable Isotope Technique to Assess Intake of Human Milk in Breastfed Infants. International Atomic Energy Agency.
[108] Sinha, S. and Loechl, C.U. (2023) Atoms for Nutrition: IAEA’s Contribution to Tackling Malnutrition. The Journal of Nutrition, 153, 10-16.[CrossRef] [PubMed]
[109] Cissé, A.S., Bluck, L., Diaham, B., Dossou, N., Guiro, A.T. and Wade, S. (2002) Use of Fourier Transformed Infrared Spectrophotometer (FTIR) for Determination of Breastmilk Output by the Deuterium Dilution Method among Senegalese Women. Food and Nutrition Bulletin, 23, 138-141.[CrossRef
[110] UNICEF and WHO (2007) Indicators for Assessing Infant and Young Child Feeding Practices. WHO and UNICEF.
https://iris.who.int/handle/10665/4389
[111] WHO (2021) Indicators for Assessing Infant and Young Child Feeding Practices: Definitions and Measurement Methods.
https://iris.who.int/handle/10665/340706
[112] Owino, V.O., Slater, C. and Loechl, C.U. (2017) Using Stable Isotope Techniques in Nutrition Assessments and Tracking of Global Targets Post-2015. Proceedings of the Nutrition Society, 76, 495-503.[CrossRef] [PubMed]
[113] Fenta, E.H., Yirgu, R., Shikur, B. and Gebreyesus, S.H. (2017) A Single 24 H Recall Overestimates Exclusive Breastfeeding Practices among Infants Aged Less than Six Months in Rural Ethiopia. International Breastfeeding Journal, 12, Article No. 36.[CrossRef] [PubMed]
[114] Liu, Z., Diana, A., Slater, C., Preston, T., Gibson, R.S., Houghton, L., et al. (2019) Development of a Nonlinear Hierarchical Model to Describe the Disposition of Deuterium in Mother-Infant Pairs to Assess Exclusive Breastfeeding Practice. Journal of Pharmacokinetics and Pharmacodynamics, 46, 1-13.[CrossRef] [PubMed]
[115] Slater, C., Kaestel, P. and Houghton, L. (2019) Assessing Breastfeeding Practices Objectively Using Stable Isotope Techniques. Annals of Nutrition and Metabolism, 75, 109-113.[CrossRef] [PubMed]
[116] IAEA (2011) Introduction to Body Composition Assessment Using the Deuterium Dilution Technique with Analysis of Saliva Samples by Fourier Transform Infrared Spectrometry. International Atomic Energy Agency.
https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1450_web.pdf

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.